Capricor Therapeutics (CAPR) Cash & Current Investments (2016 - 2025)
Historic Cash & Current Investments for Capricor Therapeutics (CAPR) over the last 17 years, with Q3 2025 value amounting to $98.6 million.
- Capricor Therapeutics' Cash & Current Investments rose 1592.09% to $98.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $98.6 million, marking a year-over-year increase of 1592.09%. This contributed to the annual value of $151.5 million for FY2024, which is 28370.4% up from last year.
- As of Q3 2025, Capricor Therapeutics' Cash & Current Investments stood at $98.6 million, which was up 1592.09% from $122.8 million recorded in Q2 2025.
- Capricor Therapeutics' Cash & Current Investments' 5-year high stood at $151.5 million during Q4 2024, with a 5-year trough of $28.5 million in Q3 2023.
- For the 5-year period, Capricor Therapeutics' Cash & Current Investments averaged around $61.9 million, with its median value being $41.9 million (2021).
- In the last 5 years, Capricor Therapeutics' Cash & Current Investments crashed by 3881.29% in 2023 and then soared by 31681.0% in 2025.
- Over the past 5 years, Capricor Therapeutics' Cash & Current Investments (Quarter) stood at $34.9 million in 2021, then grew by 18.74% to $41.4 million in 2022, then fell by 4.67% to $39.5 million in 2023, then skyrocketed by 283.7% to $151.5 million in 2024, then tumbled by 34.95% to $98.6 million in 2025.
- Its Cash & Current Investments stands at $98.6 million for Q3 2025, versus $122.8 million for Q2 2025 and $144.8 million for Q1 2025.